← Back to Search

Radiation Therapy

CyberKnife Radiosurgery for Prostate Cancer

N/A
Waitlist Available
Led By Shermian Woodhouse, MD
Research Sponsored by Community Cancer Center, Normal, Illinois
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5-10 years
Awards & highlights

Study Summary

The purpose of this study is to determine the effects of CyberKnife radiosurgery in patients with early stage prostate cancer. The investigators hypothesize that hypofractionated stereotactic radiotherapy via the CyberKnife® can deliver tumor ablating doses of radiation to prostate tumors safely and effectively while sparing the adjacent tissues (rectum, bladder, ureters, urethra, penile bulb, and bowel) from receiving damaging doses of radiation.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5-10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5-10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Local control rate
Secondary outcome measures
Overall survival

Trial Design

1Treatment groups
Experimental Treatment
Group I: CyberKnife RadiosurgeryExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CyberKnife Radiosurgery
2007
N/A
~10

Find a Location

Who is running the clinical trial?

Community Cancer Center, Normal, IllinoisLead Sponsor
1 Previous Clinical Trials
10 Total Patients Enrolled
Shermian Woodhouse, MDPrincipal InvestigatorCommunity Cancer Center
1 Previous Clinical Trials
10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors
2008. "A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02225262.
All > Sbrt
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top